FDA approves anti-obesity drug as first sleep apnea medication
The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have obesity
FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but potentially serious sleep-related breathing disorder, marking the first medication for certain patients with the condition.
Weight Loss Drug Zepbound Could Treat Sleep Apnea Without a CPAP or Surgery
GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better manage their type 2 diabetes. Now, new research suggests Eli Lilly's weight loss drug Zepbound (tirzepetide) may also support those with obstructive sleep apnea by increasing airflow and improving sleep quality.
FDA approves first medication for obstructive sleep apnea, which also promotes weight loss
The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep expert Dr. Wendy Troxel discusses the impact of the new development.
Weight loss drug Zepbound gets US FDA nod to treat sleep apnea; India launch expected in 2025
In a groundbreaking move, the US Food and Drug Administration (FDA) has approved the anti-diabetic drug Zepbound, also known as Tirzepatide, for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity.
This Popular Weight Loss Drug Can Now Be Used To Treat Sleep Apnea
Zepbound is the first medication approved to treat people with obstructive sleep apnea, said Sailly Seymor, director of FDA's division of pulmonology, allergy, and critical care.
FDA Approves Zepbound for Obstructive Sleep Apnea
FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity.
News Medical on MSN26d
Nearly half of weight loss participants reduced alcohol use after starting anti-obesity medication
Nearly half of individuals consuming alcohol at baseline reduced their alcohol consumption following the initiation of AOMs.
Health on MSN12d
Study Finds Nearly Half of People on Obesity Drugs Drink Less—But Do Scientists Know Why?
New research found that some anti-obesity medications such as Wegovy and Zepbound may prompt people to drink less. These ...
Healthline19d
Anti-obesity Medication: 7 Types
People today have many more options to help with obesity. If you are interested in trying an anti-obesity medication, talk with a doctor. GLP-1 drugs are becoming increasingly popular for their ...
The Washington Post29d
Medicare proposes covering weight-loss drugs, teeing up clash with RFK Jr.
The American Academy of Family Physicians, the American Medical Association and other medical groups have called for expanding insurance coverage for anti-obesity medication, with physicians ...
The Lantern21d
Anti-obesity medication users report increase in food waste during initial stages of use
As anti-obesity medications gain popularity ... with over 12% of the population having tried the medication at least once, and probably at least 6% of the people currently with a prescription ...
News Medical20d
Anti-obesity medications could help treat alcohol use disorders
Losing weight with anti-obesity medications (AOM) also resulted in decreased alcohol consumption for about half of the participants in a new study appearing in the current issue of JAMA Network Open.
WFAE23d
Dizzy after one drink? Social drinkers on obesity drugs lose the taste for alcohol
"The main finding is that approximately 50% of patients who consumed alcohol at baseline reported decreased alcohol use after ...
Sandoz Boss Warns There’s a Climate Cost of Obesity Wonder Drugs
Richard Saynor sees opportunity in copying cutting-edge medication and extols the merits of being boring. Richard Saynor ...